A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer

Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; Kris, M. G.; Riely, G. J.; Druker, B. J.; O'Hare, T.; Ladanyi, M.; Davare, M. A.

期刊名称Clinical Cancer Research
作者Drilon, A.; Somwar, R.; Wagner, J. P.; Vellore, N. A.; Eide, C. A.; Zabriskie, M. S.; Arcila, M. E.; Hechtman, J. F.; Wang, L.; Smith, R. S.; Kris, M. G.; Riely, G. J.; Druker, B. J.; O'Hare, T.; Ladanyi, M.; Davare, M. A.
印刷ISSN1078-0432
电子ISSN1557-3265
文件大小2784.93KB
发表时间2015-12-16
DOI10.1158/1078-0432.CCR-15-2013

发现好书期刊，享受阅读乐趣

A novel crizotinib-resistant solvent-front mutation responsive to cabozantinib therapy in a patient with ROS1-rearranged lung cancer